已收盘 11-14 16:00:00 美东时间
-0.023
-6.60%
VolitionRX (AMEX:VNRX) reported quarterly losses of $(0.05) per share which missed the analyst consensus estimate of $(0.04) by 13.64 percent. This is a 28.57 percent increase over losses of $(0.07) per share from the
11-14 05:25
Companies Reporting Before The Bell • Edgewell Personal Care (NYSE:EPC) is proj...
11-13 19:11
VolitionRX (AMEX:VNRX) will release its quarterly earnings report on Thursday, ...
11-13 02:04
HENDERSON, Nev., Oct. 17, 2025 /PRNewswire/ -- VolitionRx Limited (NYSE AMERICAN: VNRX) ("Volition"), and its subsidiary, Volition Veterinary Diagnostics Development LLC, in line with their ...
10-17 20:00
Gainers Aditxt (NASDAQ:ADTX) shares increased by 28.3% to $0.89 during Thursda...
10-10 05:06
VolitionRx (NYSE:VNRX) is proposing to offer and sell, in an underwritten public offering, shares of its common stock and accompanying common stock purchase warrants. The final terms of the proposed o...
10-10 04:14
VolitionRX shares are trading lower after the company announced a public offeri...
10-10 04:09
VolitionRx Limited (NYSE:VNRX) ("Volition" or the "Company"), a multi-national epigenetics company, announced today that it is proposing to offer and sell, in an underwritten public offering, shares of its common stock
10-10 04:07
HENDERSON, Nev., Oct. 2, 2025 /PRNewswire/ -- VolitionRx Limited (NYSE AMERICAN: VNRX) ("Volition"), a multi-national epigenetics company, today announces the sponsorship of a GenomeWeb webi...
10-02 20:45
今日重点评级关注:HC Wainwright & Co.:维持GoldMining"买入"评级,目标价从3.25美元升至3.75美元;摩根士丹利:维持Crinetics Pharmaceuticals"超配"评级,目标价从65美元升至77美元
09-30 14:16